|
CV Information
 PROFESOR DR. NORAZMI BIN MOHD NOR
| |
|---|---|
|
Grant's Name,"Project's Title" (Research Period)(Role)[Sponsorship]
| |
| 1 | OTHER MINISTRIES, "DEVELOPMENT OF A RECOMBINANT MENINGOCOCCAL ACWXY CHIMERIC PEPTIDE VACCINE" (01.07.2023 - 30.06.2025) (Principal) [ KEMENTERIAN PENGAJIAN TINGGI MALAYSIA ] - Source: eR&I |
| 2 | OTHER MINISTRIES, "IMMUNOGENICITY, TOLERABILITY AND EFFICACY OF AN ORAL TB VACCINE IN NON-HUMAN PRIMATE" (01.07.2023 - 30.06.2025) (Principal) [ KEMENTERIAN PENGAJIAN TINGGI MALAYSIA ] - Source: eR&I |
| 3 | MINISTRY OF SCIENCE, TECHNOLOGY AND INNOVATION (MOSTI), "SAFETY AND IMMUNOGENICITY OF VCUSM14P, AN ORAL COLD CHAIN FREE LIVE ATTENUATED O139 CHOLERA/TRAVELERS DIARRHOE VACCINE: A PHASE 0 FIRST-IN-HUMAN TRIAL" (01.11.2021 - 30.04.2024) (Principal) [ DANA PENYELIDIKAN STRATEGIK (SRF), MOSTI ] - Source: eR&I |
| 4 | OTHER MINISTRIES, "IMMUNOSURVEILLANCE AND HOST-ANTIGEN RESPONSE: LONGITUDINAL EVALUATION OF SPECIFIC IMMUNERESPONSES TOWARDS SAR-COV-2 FOLLOWING VACCINATION" (01.06.2021 - 31.05.2023) (Principal) [ KEMENTERIAN SAINS, TEKNOLOGI & INOVASI (MOSTI) ] - Source: eR&I |
| 5 | LONG TERM RESEARCH GRANT SCHEME (LRGS), "ENHANCING THE FUDAMENTALS OF EFFECTIVE CONTROL OF TUBERCULOSIS" (01.07.2016 - 30.06.2020) (Head Program) [ KEMENTERIAN PENGAJIAN TINGGI ] - Source: eR&I |
| 6 | LONG TERM RESEARCH GRANT SCHEME (LRGS), "SUBPROJEK 1.1 : DEVELOPMENT OF DETECTION METHODS FOR ACTIVE, LATENT & MDR-TB INFECTION" (01.07.2016 - 30.06.2020) (Team Member) [ KEMENTERIAN PENGAJIAN TINGGI ] - Source: eR&I |
| 7 | LONG TERM RESEARCH GRANT SCHEME (LRGS), "SUBPROJEK 1.2 : DEVELOPMENT OF POTENTIAL BIOLOGICAL AS THE THERAPEUTICS AND PROPHYLACTICS AGAINST TB" (01.07.2016 - 30.06.2020) (Team Member) [ KEMENTERIAN PENGAJIAN TINGGI ] - Source: eR&I |
| 8 | EXTERNAL AGENCY (GOVERNMENT AGENCIES), "TUBERCULOSIS VACCINE AND DIAGNOSTIC DEVELOPMENT PROGRAMME" (01.09.2011 - 28.02.2013) (Principal) [ MOSTI (ER-BIOTEK) ] - Source: eR&I |
| 9 | LONG TERM RESEARCH GRANT SCHEME (LRGS), "TROPICAL TUBERCULOSIS : DELINEATING HOST-ENVIRONMENT-PATHOGEN INTERACTIONS" (01.08.2011 - 31.08.2014) (Head Program) [ KEMENTERIAN PENDIDIKAN MALAYSIA ] - Source: eR&I |
| 10 | LONG TERM RESEARCH GRANT SCHEME (LRGS), "HOST IMMUNOGENETICS AND SUSCEPTIBILITY TO M. TUBERCULOSIS - TOWARDS A RATIONAL DESIGN OF VACCINES AGAINST M. TUBERCULOSIS" (01.08.2011 - 31.08.2014) (Team Member) [ KEMENTERIAN PENGAJIAN TINGGI ] - Source: eR&I |
| 11 | FUNDAMENTAL RESEARCH GRANT SCHEME (FRGS), "ASSOCIATION OF SELECTED MIRNAS IN SUSCEPTIBILITY AND RESISTANCE TO TUBERCULOSIS" (01.04.2011 - 31.03.2013) (Principal) [ KEMENTERIAN PENGAJIAN TINGGI ] - Source: eR&I |
| 12 | EXTERNAL AGENCY (GOVERNMENT AGENCIES), "ENHANCING STRATEGIES FOR THE DEVELOPMENT OF TUBERCULOSIS CANDIDATE VACCINES" (01.03.2007 - 28.02.2009) (Principal) [ J/KUASA TEKNIKAL & J/KUASA STRATEGIK DALAMAN BIOTEK ] - Source: eR&I |
| 13 | EXTERNAL AGENCY (GOVERNMENT AGENCIES), "FORMULATION OF BCG FOR THE EFFECTIVE DELIVERY OF MALARIAL EPITOPES" (01.03.2007 - 31.12.2009) (Principal) [ INSTITUT FARMASEUTIKAL & NUTRASEUTIKAL MALAYSIA (IFNM) ] - Source: eR&I |
| 14 | SCIENTIFIC ADVANCEMENT GRANT SCHEME, "ELUCIDATION OF THE MAP KINASE TRANSDUCTION PATHWAY(S) INVOLVED IN IL-2- INDUCED CD4+CD25+ T CELL ACTIVATION - POSSIBLE INTERACTIONS AS THE RELEVANT TRANSCRIPTION FACTORS WITH PPARY2 AND FOXP3" (01.03.2005 - 30.04.2007) (Principal) [ AKADEMI SAINS MALAYSIA ] - Source: eR&I |
| 15 | FUNDAMENTAL RESEARCH GRANT SCHEME (FRGS), "EVALUATION OF THE IMMUNOLOGICAL MECHANISMS INDUCED BY RECOMBINANT BCG CLONES EXPRESSING T AND B CELL EPITOPES OF MYCOBACTERIUM TUBERCULOSIS." (01.08.2003 - 31.07.2006) (Principal) [ FRGS ] - Source: eR&I |
| 16 | FUNDAMENTAL RESEARCH GRANT SCHEME (FRGS), "THE ROLE OF PPARA AND PPARY IN T CELL ACTIVATION" (01.07.2002 - 30.06.2004) (Principal) [ FRGS ] - Source: eR&I |
| 17 | IRPA, "THE ROLE OF PPARY IN THE REGULATION OF IMMUNE ACTIVATION" (01.07.2002 - 30.06.2005) (Principal) [ RM8 ] - Source: eR&I |
| 18 | IRPA, "DEVELOPMENT OF RECOMBINANT BACILLE CALMETTE GUERIN (BCG) AS A MULTIVALENT VACCINE AGAINST MALARIA AND TUBERCULOSIS" (01.01.2002 - 31.12.2004) (Principal) [ RM8 ] - Source: eR&I |
| 19 | EXTERNAL AGENCY (GOVERNMENT AGENCIES), "MOLECULAR STUDIES ON DISEASE BIOMARKERS AND PATHOGENESIS OF CANCER : COLORECTAL CARCINOMA AS A MODEL" (01.01.2002 - 31.12.2004) (Principal) [ INSTITUT PENYELIDIKAN PERUBATAN (IMR) ] - Source: eR&I |
| 20 | IRPA, "CONSTRUCTION, IMMUNOGENICITY AND EFFICACY OF RECOMBINANT MYCOBACTERIUM BOVIS BACILLE CALMETTE-GUERIN (BCG) CONTAINING 2-P. FALCIPARUM CANDIDATE EPITOPES AS MALARIAL VACCINE" (01.10.2000 - 30.09.2003) (Principal) [ RM7 ] - Source: eR&I |
| 21 | IRPA, "CLONING AND EXPRESSION OF THE MURINE MALARIA PARASITE PALASMODIUM BERGHEI BLOOD STAGE ANTIGENTS IN MYCOBACTERIUM BOVIS BACILLE CALMETTA GUERIN (BCG)" (01.10.1999 - 30.09.2001) (Principal) [ RM7 ] - Source: eR&I |
| 22 | IRPA, "DEVELOPMENT OF RECOMBINANT BECILLE CALMETTE-GUERIN (BCG) AS MALARIAL VACCINE." (01.04.1997 - 31.03.2000) (Principal) [ RM7 ] - Source: eR&I |
| 23 | EXTERNAL AGENCY (INDUSTRY/PRIVATE), "CONSTRUCTION OF RECOMBINANT M BOVIS BCG CONTAINING THE ERYTHROCYTE BINDING ANTIGEN (EBA) OF P FACIPARUM - POTENTIAL USE AS A MALARIAL VACCINE" (09.12.1996 - 05.06.2000) (Principal) [ MALAYSIA TORAY SCIENCE FOUNDATION (MTSF) ] - Source: eR&I |
| 24 | EXTERNAL AGENCY (INDUSTRY/PRIVATE), "CONSTRUCTION OF RECOMBINANT M BOVIS BCG CONTAINING THE ERYTHROCYTE BINDING ANTIGEN (EBA) OF P FALCIPARUM POTENTIAL USE AS A MALARIAL VACCINE" (01.01.1996 - 01.01.1970) (Principal) [ MALAYSIA TORAY SCIENCE FOUNDATION (MTSF) ] - Source: eR&I |
| 25 | IRPA, "T-CELL IMMUNITY IN FALCIPARUM MALARIA" (01.01.1993 - 31.12.1993) (Principal) [ RM6 ] - Source: eR&I |